Literature DB >> 18560842

Babies with myelomeningocele in Poland: parents' attitudes on fetal surgery versus termination of pregnancy.

Tomasz Koszutski1, Henryk Kawalski, Grzegorz Kudela, Jolanta Wróblewska, Katarzyna Byrka-Owczarek, Janusz Bohosiewicz.   

Abstract

BACKGROUND: Recent surgical advances have resulted in fetal surgery becoming an option for children with myelomeningocele (MMC). However, there is little information about the parents' attitudes towards such therapy.
METHODS: Following a lecture on the current status and problems of fetal surgery for MMC, a 12-item questionnaire was administered to 58 parents of children with MMC. Questionnaire topics included knowledge of the disease and treatment options, as well as attitudes and concerns towards fetal surgery or termination of pregnancy.
RESULTS: Following the lecture, 14 (out of 58) parents felt that knowledge of the disease would allow for abortion to be an option, while 18 were uncertain. Once informed of potential risks and benefits of fetal surgery, 34 parents had a positive or rather positive attitude towards this procedure.
CONCLUSIONS: On the basis of these results, it was concluded that this population is potentially interested in the use of fetal surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18560842     DOI: 10.1007/s00381-008-0653-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

Review 1.  Fetal surgery for myelomeningocele: panacea or peril?

Authors:  Shinjiro Hirose; Claudia Meuli-Simmen; Martin Meuli
Journal:  World J Surg       Date:  2003-01       Impact factor: 3.352

2.  Embryological stages in the establishing of myeloschisis with spina bifida.

Authors:  B M PATTEN
Journal:  Am J Anat       Date:  1953-11

3.  Fetal surgery for myelomeningocele.

Authors:  Leslie N Sutton; N Scott Adzick
Journal:  Clin Neurosurg       Date:  2004

Review 4.  Myelomeningocele in young adults.

Authors:  Christopher R J Woodhouse
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

Review 5.  Fetal magnetic resonance imaging as a complement to fetal ultrasonography.

Authors:  Dorothy Bulas
Journal:  Ultrasound Q       Date:  2007-03       Impact factor: 1.657

6.  Endoscopic coverage of fetal open myelomeningocele in utero.

Authors:  J P Bruner; N E Tulipan; W O Richards
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

Review 7.  Current diagnosis and management of fetal genitourinary abnormalities.

Authors:  Katherine C Hubert; Jeffrey S Palmer
Journal:  Urol Clin North Am       Date:  2007-02       Impact factor: 2.241

8.  The National Institutes of Health Workshop on Fetal Treatment: needs assessment and future directions.

Authors:  Nancy C Chescheir; Michael Socol
Journal:  Obstet Gynecol       Date:  2005-10       Impact factor: 7.661

9.  In utero meconium exposure increases spinal cord necrosis in a rat model of myelomeningocele.

Authors:  Jorge Correia-Pinto; Joaquim L Reis; Grover M Hutchins; Maria J Baptista; José Estevão-Costa; Alan W Flake; Adelino F Leite-Moreira
Journal:  J Pediatr Surg       Date:  2002-03       Impact factor: 2.545

10.  Ethics: "life before birth" and moral complexity in maternal-fetal surgery for spina bifida.

Authors:  Mark J Bliton
Journal:  Clin Perinatol       Date:  2003-09       Impact factor: 3.430

View more
  3 in total

1.  Determination of the Effect of Diameter of the Sac on Prognosis in 64 Cases Operated for Meningomyelocele.

Authors:  Metehan Eseoğlu; Ahmet Eroğlu; Serkan Kemer; Mehmet Arslan
Journal:  Korean J Spine       Date:  2017-03-31

2.  The effect of surgery time on prognosis in newborns with meningomyelocele.

Authors:  Mehmet Yekta Oncel; Ramazan Ozdemir; Gokmen Kahilogulları; Sadık Yurttutan; Omer Erdeve; Ugur Dilmen
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

3.  A study to assess global availability of fetal surgery for myelomeningocele.

Authors:  Adalina Sacco; Lynn Simpson; Jan Deprest; Anna L David
Journal:  Prenat Diagn       Date:  2018-11-20       Impact factor: 3.242

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.